Enveric Biosciences (ENVB) Invested Capital (2010 - 2021)

Enveric Biosciences has reported Invested Capital for 9 years, with the latest figure at $148604.0 in Q2 2021.

• Quarterly Invested Capital fell 93.64% year-over-year to $148604.0 in Q2 2021, while the trailing twelve-month figure through Mar 2022 was $148604.0 (down 96.35% YoY) and the FY2019 annual result came in at $22409.0, up 247.43% from the prior year.
• Invested Capital eased to $148604.0 in Q2 2021 per ENVB's latest filing, from $1.7 million in the prior quarter.
• Over five years, Invested Capital peaked at $4.6 million in Q1 2020 and troughed at $6450.0 in Q4 2018.
• A 5-year average of $2.3 million and a median of $2.3 million in 2018 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 786.64% in 2018, down 99.84% in 2018.
• Over 5 years, Invested Capital stood at $4.1 million in 2017, then slumped by 99.84% to $6450.0 in 2018, then soared by 247.43% to $22409.0 in 2019, then jumped by 7618.33% to $1.7 million in 2020, then tumbled by 91.41% to $148604.0 in 2021.
• According to Business Quant data, Invested Capital over the past three periods registered $148604.0, $1.7 million, and $2.3 million for Q2 2021, Q3 2020, and Q2 2020 respectively.